The effects of pentoxifylline administration on NFΚB P50 transcription factor expression.

about

Efficacy and safety evaluation of pentoxifylline associated with other antioxidants in medical treatment of Peyronie's disease: a case-control study.

P2860

Q43099012-2B4F51C2-7CC5-43F6-801B-275E8224CAA2

P2860

The effects of pentoxifylline administration on NFΚB P50 transcription factor expression.

Item

http://www.wikidata.org/entity/Q36144610

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

The effects of pentoxifylline administration on NFΚB P50 transcription factor expression.

@ast

The effects of pentoxifylline administration on NFΚB P50 transcription factor expression.

@en

type

Item

label

The effects of pentoxifylline administration on NFΚB P50 transcription factor expression.

@ast

The effects of pentoxifylline administration on NFΚB P50 transcription factor expression.

@en

prefLabel

The effects of pentoxifylline administration on NFΚB P50 transcription factor expression.

@ast

The effects of pentoxifylline administration on NFΚB P50 transcription factor expression.

@en

P1476

The effects of pentoxifylline administration on NFΚB P50 transcription factor expression

@en

P2093

Amir Hooshang Mohammadpour

http://www.w3.org/2001/XMLSchema#string

Homa Falsoleiman

http://www.w3.org/2001/XMLSchema#string

Jamal Shamsara

http://www.w3.org/2001/XMLSchema#string

Javad Behravan

http://www.w3.org/2001/XMLSchema#string

Mohammad Ramezani

http://www.w3.org/2001/XMLSchema#string

P2860

Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis

A pattern of protein expression in peripheral blood mononuclear cells distinguishes rheumatoid arthritis patients from healthy individuals.

The human peripheral blood mononuclear cell proteome responds to a dietary flaxseed-intervention and proteins identified suggest a protective effect in atherosclerosis.

Proteomic biomarkers of peripheral blood mononuclear cells obtained from postmenopausal women undergoing an intervention with soy isoflavones.

A proteomic study of peripheral blood mononuclear cells in systemic lupus erythematosus.

Inhibition by pentoxifylline of TNF-alpha-stimulated fractalkine production in vascular smooth muscle cells: evidence for mediation by NF-kappa B down-regulation.

C-reactive protein, inflammatory conditions, and cardiovascular disease risk

Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction.

Atherosclerosis-underlying inflammatory mechanisms and clinical implications.

Inflammatory biomarkers, race/ethnicity and cardiovascular disease.

P304

133-137

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23205044

http://www.w3.org/2001/XMLSchema#string

P932

3413080

http://www.w3.org/2001/XMLSchema#string

The effects of pentoxifylline administration on NFΚB P50 transcription factor expression.

about

P2860

P2860

The effects of pentoxifylline administration on NFΚB P50 transcription factor expression.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932